A unique suite of programs
Our pipeline includes multiple programs at several stages. We focus on both common and orphan indications with an emphasis on delivering precision medicines to patients with diseases of great unmet medical need. Our priority therapeutic areas of interest are inflammation-immunology, fibrosis, and kidney diseases. Other disease indications with strong human genetic validation may also be considered and pursued.